Who
Ori Gutwerg
SVP, Generics
Company insider
Files Form 4 as: SVP, Generics, ANI Pharmaceuticals.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $3.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Feb 2021
- Last trade
- 10 Aug 2026
- Last filed
- 11 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 11 Aug 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $243K3,162 at $77.00 | filing |
| 10 Aug 2026filed 11 Aug 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $243K3,162 at $77.00 | filing |
| 12 May 2026filed 13 May 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $220K2,772 at $79.50 | filing |
| 12 May 2026filed 13 May 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $220K2,772 at $79.50 | filing |
| 7 Mar 2026filed 10 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $245K3,314 at $74.04 | filing |
| 7 Mar 2026filed 10 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $245K3,314 at $74.04 | filing |
| 3 Mar 2026filed 4 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $158K2,060 at $76.50 | filing |
| 3 Mar 2026filed 4 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $158K2,060 at $76.50 | filing |
| 28 Feb 2026filed 2 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $164K2,221 at $73.90 | filing |
| 28 Feb 2026filed 2 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $164K2,221 at $73.90 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | $1.0M12,969 at $77.15 | filing |
| 26 Feb 2026filed 2 Mar 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | $1.0M12,969 at $77.15 | filing |
| 14 Feb 2026filed 17 Feb 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $146K1,888 at $77.36 | filing |
| 14 Feb 2026filed 17 Feb 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $146K1,888 at $77.36 | filing |
| 12 Feb 2026filed 17 Feb 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $136K1,775 at $76.70 | filing |
| 12 Feb 2026filed 17 Feb 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $136K1,775 at $76.70 | filing |
| 11 Feb 2026filed 13 Feb 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $325K4,267 at $76.25 | filing |
| 11 Feb 2026filed 13 Feb 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $325K4,267 at $76.25 | filing |
| 12 Aug 2025filed 14 Aug 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $508K5,873 at $86.53 | filing |
| 15 May 2025filed 16 May 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $53K881 at $60.07 | filing |
News
ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ETANIP · manilatimes.net · 23 Oct 2026ANI Pharmaceuticals Report Two-Year Vision Improvements In Phase 4 Eye Disease StudyANIP · rttnews.com · 12 Oct 2026
0 headlines in the last 90 days name Ori Gutwerg; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.